Biobrewhouse

What is the future of clinical trials?

Stephane van Rooijen (CEO at Flamingo Therapeutics), Eric Van Cutsem (President Stichting tegen Kanker), Patrik De Haes (Chairman Biobrewhouse) and Antonio Vila-Coro (Senior Director at IQVIA) will elaborate on this topic on September 26th in Leuven.

Because for many of our start-ups real life only starts when the first patients are being recruited. As from that moment investor interest gets real.

At this Biobrewhouse event, organized by Leuven MindGate, flanders.bio and KU Leuven Research & Development, these three speakers will deep-dive into the topic of clinical trials. Hence we have the academic view, the technical CRO view and the perspective of the start up company.

The presentations are interactive and take max 15 mins with 5 mins Q&A so that we can all have a drink together afterwards. Biobrewhouse is completely free if you register before Sept 18!

Program:

• 17h00 - Introduction
  
  Patrik De Haes MD, Chairman Biobrewhouse
  
  
  
• 17h15 - Clinical Development of drugs and devices in an academic setting : my personal experience in oncology.
  
  Prof Eric Van Cutsem, MD, PhD
  Gastroenterology / Digestive Oncology
  University Hospitals Gasthuisberg / Leuven & KULeuven
  President Stichting tegen Kanker
  
  
  
• 17h40 - Clinical trials in the future : latest perspectives on Novel Trial Designs
  
  Antonio Vila-Coro
  Senior Director Client Partner
  IQVIA
  
  
  
• 18h05 - The future of clinical trial development : a strategic and commercial perspective
  
  Stephane van Rooijen MD, MBA
  CEO Flamingo Therapeutics
  
  
  
• 18h30 - Reception